as on September 16, 2025 at 8:36 pm IST
Day's Low
Day's High
0.09%
Downside
2.47%
Upside
52 Week's Low
52 Week's High
6.51%
Downside
205.15%
Upside
Check Janux Therapeutics Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$1.4B
EPS (TTM)
-2.2589
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
0.00%
PE Ratio (TTM)
-52.87
Industry PE ratio
10.127857142857144
P/B Ratio
0PEG Ratio
0EBITDA
-142.8M
Revenue (TTM)
439.0K
Profit Margin
0.00%
Return On Equity TTM
5314200.00%
Track how Janux Therapeutics Inc P/E has moved over time to understand its valuation trends.
Janux Therapeutics Inc in the last 5 years
Lowest (0.00x)
September 16, 2025
Today (-52.87x)
September 16, 2025
Industry (10.13x)
September 16, 2025
Highest (0.00x)
September 16, 2025
Today’s Price to Earnings Ratio: -52.87x
Compare market cap, revenue, PE, and other key metrics of Janux Therapeutics Inc with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
---|---|---|---|---|---|
BUY | $1.4B | NA | -52.87 | 0.00% | |
BUY | $61.1B | 251.26% | -505.15 | -12.96% | |
NA | $38.7B | NA | NA | -3.89% | |
BUY | $101.2B | 47.46% | 28.09 | 31.86% | |
BUY | $59.6B | 0.6% | 14.1 | 31.37% |
The Janux Therapeutics Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Janux Therapeutics Inc investment value today
Current value as on today
₹51,971
Returns
Returns from Janux Therapeutics Inc Stock
Dollar Returns*
₹4,867 (+4.87%)
Based on 15 analysts
93.33%
Buy
6.67%
Hold
0.00%
Sell
Based on 15 analysts, 93.33% of analysts recommend a 'BUY' rating for Janux Therapeutics Inc. Average target price of $80.56
Get share price movements and forecasts by analysts on Janux Therapeutics Inc.
What analysts predicted
70.83%UPSIDE
Target Price
$80.56
Current Price
$23.5
Analyzed by
15 Analysts
Target
$80.56
Janux Therapeutics Inc target price $80.56, a slight upside of 70.83% compared to current price of $23.5. According to 15 analysts rating.
Search interest for Janux Therapeutics Inc Stock has decreased by -14% in the last 30 days, reflecting a downward trend in search activity.
Time period: to
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Against Peers
In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 116.5% return, outperforming this stock by 31.9%
Against Peers
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 70.6% return, outperforming this stock by 123.4%
Revenue Fall
Revenue is down for the last 3 quarters, 8.89M → -8.51M (in $), with an average decrease of 1067.0% per quarter
Price Dip
In the last 1 month, JANX stock has moved down by -6.2%
Profit Down
Netprofit is down for the last 3 quarters, -20.21M → -33.85M (in $), with an average decrease of 30.2% per quarter
Organisation | Janux Therapeutics Inc |
Headquarters | 10955 Vista Sorrento Parkway, San Diego, CA, United States, 92130 |
Industry | Services |
CEO | Dr. David Alan Campbell Ph.D. |
E-voting on shares | Click here to vote |
Name | Title |
---|---|
Ms. Janeen Doyle | Chief Corporate & Business Development Officer |
Mr. Andy Hollman Meyer | Chief Business Officer |
Dr. David Alan Campbell Ph.D. | President, CEO & Director |
Dr. Thomas Diraimondo Ph.D. | Chief Scientific Officer |
Mr. Byron Robinson J.D., Ph.D. | Chief Strategy Officer |
Mr. James Pennington | General Counsel & Corporate Secretary |
Mr. Matt Whitmire | Vice President of Finance |
Ms. Maria Dobek | Principal Accounting Officer & VP of Accounting |
Mr. Charles M. Winter | Chief Technical Officer |
Dr. Zachariah McIver D.O., Ph.D. | Chief Medical Officer |
Janux Therapeutics Inc share price today is $23.5 as on . Janux Therapeutics Inc share today touched a day high of $24.08 and a low of $23.48.
Janux Therapeutics Inc share touched a 52 week high of $71.71 on and a 52 week low of $21.97 on . Janux Therapeutics Inc stock price today i.e. is trending at $23.5,which is 67.23% down from its 52 week high and 6.96% up from its 52 week low.
Janux Therapeutics Inc market capitalisation is $0.00T as on .
Indian investors can start investing in Janux Therapeutics Inc (JANX) shares with as little as ₹88.042 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹880.42 in Janux Therapeutics Inc stock (as per the Rupee-Dollar exchange rate as on ).
Based on Janux Therapeutics Inc share’s latest price of $23.5 as on September 16, 2025 at 8:36 pm IST, you will get 0.4255 shares of Janux Therapeutics Inc. Learn more about
fractional shares .